Phase 3 b
Phase 3 b is a subcategory of a Phase 3 clinical trial that is performed near the time of approval to elicit additional findings. (CDISC)
Phase 3 b is a subcategory of a Phase 3 clinical trial that is performed near the time of approval to elicit additional findings. (CDISC)
Support Provided by AbbVie, Amgen, AstraZeneca, Bristol Myers Squibb, Eisai, Genentech, Merck, and Sanofi.
